TP53 and colon adenocarcinoma: Interestingly, the established prognostic signature can distinguish COAD with worse outcome as high risk only in those with TP53 mutations instead of in those with TP53 wild-type, which suggested that the established prognostic signature had potential to be a novel risk classification especially for patients with TP53-mutant COAD.